KNSA
Kiniksa Pharmaceuticals Ltd
74.60$
-1.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +129.1% | +93.1% | +0.0% | |
| – | +27.3% | +921.4% | +623.1% | +16.3% | -2.1% | +2.0% | -2.5% | -27.6% | +0.0% | |
| – | +143.8% | +535.6% | +164.5% | +38.4% | +20.6% | -0.2% | +8.1% | +13.1% | +0.0% | |
| – | +117.4% | +584.1% | +149.4% | +111.3% | +0.2% | -734.1% | – | – | – | |
| – | +690.4% | +31.6% | -192.9% | – | – | -3,376.5% | – | +1,737.7% | +108.1% | |
| – | +2,200.0% | +7,566.7% | -39.5% | -91.2% | +7,113.8% | -99.5% | +23.8% | +113.1% | +0.0% | |
| – | +2,200.0% | +346,563.8% | – | -147.6% | – | -106.3% | +265.9% | – | +0.0% | |
| – | -6.2% | +778.8% | -76.0% | -92.2% | -10.2% | -115.3% | +144.8% | +125.9% | +55.1% | |
| – | -6.2% | +769.6% | -75.7% | +170.0% | -97.4% | -57.2% | -40.6% | +720.5% | +0.0% | |
| – | -150.5% | – | -194.4% | – | -87.7% | -97.0% | -6,124.9% | – | +0.0% | |
| – | – | – | – | – | – | – | +131.0% | +92.9% | +0.0% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.